Wednesday, January 18, 2006

Pfizer prevails over Apotex concerning amlodipine besylate (NORVASC)

Judge James Rosenbaum in ND Ill ruled that Pfizer's patent covering the active ingredient in Norvasc -- amlodipine besylate -- was valid and infringed by Apotex's product. [Jan. 18, 2006]



[IPBiz post 1158]

0 Comments:

Post a Comment

<< Home